Perfiles de resistencia a fluoroquinolonas en cocos Gram positivos de importancia clínica

  • Maribel Josefina Castellano-González 1Universidad del Zulia. Facultad de Medicina. Escuela de Bioanálisis. Departamento de Microbiología. Cátedra de Bacteriología General. Maracaibo-Zulia http://orcid.org/0000-0002-1992-8349
  • José Daniel Ocando-Chávez Universidad del Zulia. Facultad de Medicina. Escuela de Bioanálisis. Departamento de Microbiología. Maracaibo-Zulia
  • Anyimar Carolina Serrano Azuaje Universidad del Zulia. Facultad de Medicina. Escuela de Bioanálisis. Departamento de Microbiología. Maracaibo-Zulia
  • Isabelle Virginia Sandoval-Castellano Universidad del Zulia. Facultad de Medicina. Escuela de Medicina. Maracaibo-Zulia. Venezuela
Palabras clave: Fluoroquinolonas, cocos Gram positivos, resistencia a antibióticos, Staphylococcus, Enterococcus, Streptococcus.

Resumen

Para evaluar la resistencia a fluoroquinolonas en aislamientos clínicos de cocos grampositivos se revisaron los resultados de los cultivos procesados en el Centro de Referencia Bacteriológica del Servicio Autónomo Hospital Universitario de Maracaibo, durante el periodo enero 2011-diciembre 2015. Los datos fueron analizados mediante el software WHONETTM, (versión 5,6) y el IBM® SPSS® Statistics para Windows, (versión 25). Se encontró una prevalencia de 29,70% para los cocos grampositivos (9.292 cepas), correspondiendo el 76,18% de los aislamientos al género Staphylococcus (7.072); 15,30% a Enterococcus (1.422) y 8,59% a Streptococcus (798). Para Staphylococcus, la resistencia fue mayor en cepas resistentes a meticilina. Las tasas de resistencia más elevadas se detectaron en los enterococos, especialmente en Enterococcus faecium resistente a vancomicina. No se detectó resistencia a fluoroquinolonas en las cepas de Enterococcus faecalis resistentes a vancomicina. Los estreptococos, incluyendo Streptococcus pneumoniae, se mostraron, mayormente, sensibles a las fluoroquinolonas. La mayoría de las cepas de estafilococos y enterococos; presentó, resistencia cruzada a todas las fluoroquinolonas probadas. La distribución de la resistencia a las fluoroquinolonas por año de estudio en cada género bacteriano fue diferente. La resistencia a las fluoroquinolonas muestra una tendencia creciente en los tres géneros de cocos grampositivos evaluados

Biografía del autor/a

Maribel Josefina Castellano-González, 1Universidad del Zulia. Facultad de Medicina. Escuela de Bioanálisis. Departamento de Microbiología. Cátedra de Bacteriología General. Maracaibo-Zulia

Profesora Titular de la Cátedra de Bacteriología General de la Escuela de Bioanálisis de la Universidad del Zulia.

jefe del Departamento de Microbiología de la Escuela de Bioanálisis de LUZ

 

Citas

Ezelarab HAA, Abbas SH, Hassan HA, Abuo-Rahma GE-DA. Recent updates of fluoroquinolones as antibacterial agents. Arch Pharm (Weinheim) [Internet]. 1 de septiembre de 2018;351(9):1800141. Disponible en: https://doi.org/10.1002/ardp.201800141 DOI: 10.1002/ardp.201800141 PMID 30048015 Google Académico Microsoft Académico

Aldred KJ, Kerns RJ, Osheroff N. Mechanism of Quinolone Action and Resistance. Biochemistry [Internet]. 18 de marzo de 2014;53(10):1565-74. Disponible en: https://doi.org/10.1021/bi5000564 DOI: 10.1021/bi5000564 PMID 24576155 PMCID PMC3985860 Google Académico Microsoft Académico

Álvarez-Hernández DA, Garza-Mayén GS, Vázquez-López R. Quinolonas: Perspectivas actuales y mecanismos de resistencia. Rev Chil Infectología [Internet]. 2015;32(5):499-504. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-10182015000600002&lng=en&nrm=iso&tlng=en DOI: 10.4067/S0716-10182015000600002 SciELO Lilacs PMID 26633105 Google Académico Microsoft Académico

Redgrave LS, Sutton SB, Webber MA, Piddock LJ V. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol [Internet]. 1 de agosto de 2014;22(8):438-45. Disponible en: https://doi.org/10.1016/j.tim.2014.04.007 DOI: 10.1016/j.tim.2014.04.007 PMID 24842194 Google Académico Microsoft Académico

Bisacchi GS. Origins of the Quinolone Class of Antibacterials: An Expanded “Discovery Story”. J Med Chem [Internet]. 25 de junio de 2015;58(12):4874-82. Disponible en: https://doi.org/10.1021/jm501881c DOI: 10.1021/jm501881c PMID 25738967 Google Académico Microsoft Académico

Kim ES, Hooper DC. Clinical Importance and Epidemiology of Quinolone Resistance. Infect Chemother [Internet]. diciembre de 2014;46(4):226-38. Disponible en: https://doi.org/10.3947/ic.2014.46.4.226 DOI: 10.3947/ic.2014.46.4.226 PMID 25566402 PMCID PMC4285002 Google Académico Microsoft Académico

Collignon PC, Conly JM, Andremont A, McEwen SA, Aidara-Kane A, for the World Health Organization Advisory Group BM on IS of AR (WHO-A, et al. World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production. Clin Infect Dis [Internet]. 15 de octubre de 2016;63(8):1087-93. Disponible en: https://doi.org/10.1093/cid/ciw475 DOI: 10.1093/cid/ciw475 PMID 27439526 Google Académico Microsoft Académico

World Health Organization. WHO Model Lists of Essential Medicines [Internet]. [citado 5 de enero de 2019]. Disponible en: https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists

Hooper DC, Jacoby GA. Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance. Cold Spring Harb Perspect Med [Internet]. septiembre de 2016;6(9). Disponible en: http://perspectivesinmedicine.cshlp.org/cgi/pmidlookup?view=long&pmid=27449972 DOI: 10.1101/cshperspect.a025320 PMID 27449972 PMCID PMC5008060 Google Académico Microsoft Académico

Fair RJ, Tor Y. Antibiotics and Bacterial Resistance in the 21st Century. Perspect Medicin Chem [Internet]. 1 de enero de 2014;6:25-64. Disponible en: https://doi.org/10.4137/PMC.S14459 DOI: 10.4137/PMC.S14459 PMID 25232278 PMCID PMC4159373 Google Académico Microsoft Académico

U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States [Internet]. Centers for Disease Control and Prevention. Washington DC: Centers for Disease Control and Prevention; 2013 [citado 5 de enero de 2019]. Disponible en: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf

World Health Organization. Antimicrobial Resistance Global Report on Surveillance [Internet]. Geneva-Switzerland: World Health Organization; 2014 [citado 5 de enero de 2029]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf;jsessionid=F52C3917F9ADF9A8868A9B1184F66523?sequence=1

Yezli S, Shibl AM, Livermore DM, Memish ZA. Antimicrobial resistance among Gram-positive pathogens in Saudi Arabia. J Chemother [Internet]. 1 de junio de 2012;24(3):125-36. Disponible en: https://doi.org/10.1179/1973947812Y.0000000010 DOI: 10.1179/1973947812Y.0000000010 PMID 22759756 Google Académico Microsoft Académico

Xu J, Chen Q, Yao H, Zhou Q. Changes of the Quinolones Resistance to Gram-positive Cocci Isolated during the Past 8 Years in the First Bethune Hospital. Phys Procedia [Internet]. 2012;33:1205-7. Disponible en: https://www.sciencedirect.com/science/article/pii/S187538921201512X DOI: 10.1016/j.phpro.2012.05.199 Google Académico Microsoft Académico

Dalhoff A. Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use. Interdiscip Perspect Infect Dis [Internet]. 2012;2012:976273. Disponible en: https://doi.org/10.1155/2012/976273 DOI: 10.1155/2012/976273 PMID 23097666 PMCID PMC3477668 Google Académico Microsoft Académico

Hernández R, Fernández C, Baptista P. Metodología de la investigación. En: 6.a ed. Mexico DF. Mexico: McGraw-Hill/Interamericana Editores, S.A. de C.V; 2014. p. 634.

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI. Supplement M100-S29. Wayne PA: Clinical and Laboratory Standards Institute; 2019. 296 p.

Asociación Médica Mundial. Declaración de Helsinki de la AMM. Principios éticos para las investigaciones médicas en seres humanos [Internet]. 2019 [citado 14 de mayo de 2020]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

Rossolini GM, Mantengoli E, Montagnani F, Pollini S. Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents. Curr Opin Microbiol [Internet]. 2010;13(5):582-8. Disponible en: https://www.sciencedirect.com/science/article/pii/S1369527410001207 DOI: 10.1016/j.mib.2010.08.006 Google Académico Microsoft Académico

Matta R, Hallit S, Hallit R, Bawab W, Rogues A-M, Salameh P. Epidemiology and microbiological profile comparison between community and hospital acquired infections: A multicenter retrospective study in Lebanon. J Infect Public Health [Internet]. 2018;11(3):405-11. Disponible en: https://www.sciencedirect.com/science/article/pii/S1876034117302393 DOI: 10.1016/j.jiph.2017.09.005 PMID 28970096 Google Académico Microsoft Académico

Lozano-Huntelman NA, Singh N, Valencia A, Mira P, Sakayan M, Boucher I, et al. Evolution of antibiotic cross-resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window. Evol Appl [Internet]. 1 de abril de 2020;13(4):808-23. Disponible en: https://doi.org/10.1111/eva.12903 DOI: 10.1111/eva.12903 PMID 32211069 PMCID PMC7086048 Google Académico Microsoft Académico

Luo R, Cannon L, Hernandez J, Piovoso MJ, Zurakowski R. Controlling the evolution of resistance. J Process Control [Internet]. 2011;21(3):367-78. Disponible en: https://www.sciencedirect.com/science/article/pii/S0959152410002283 DOI: 10.1016/j.jprocont.2010.11.010 PMID 21516198 PMCID PMC3079266 Google Académico Microsoft Académico

Dorobăţ OM, Bădicuţ I, Tălăpan D, Tenea C, Rafila A. [Antibiotic resistance of Gram-positive cocci isolated in 2008]. Bacteriol Virusol Parazitol Epidemiol (Bucur). 2010;55(2):83-92. PMID 21553473 Google Académico Microsoft Académico

Sisay M, Weldegebreal F, Tesfa T, Ataro Z, Marami D, Mitiku H, et al. Resistance profile of clinically relevant bacterial isolates against fluoroquinolone in Ethiopia: a systematic review and meta-analysis. BMC Pharmacol Toxicol [Internet]. 2018;19(1):86. Disponible en: https://doi.org/10.1186/s40360-018-0274-6 DOI: 10.1186/s40360-018-0274-6 PMID 30541613 PMCID PMC6292079 Google Académico Microsoft Académico

Yılmaz EŞ, Aslantaş Ö. Antimicrobial resistance and underlying mechanisms in Staphylococcus aureus isolates. Asian Pac J Trop Med [Internet]. 2017;10(11):1059-64. Disponible en: https://www.sciencedirect.com/science/article/pii/S1995764517311318 DOI: 10.1016/j.apjtm.2017.10.003 PMID 29203102 Google Académico Microsoft Académico

Bax BD, Murshudov G, Maxwell A, Germe T. DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion. J Mol Biol [Internet]. 2019;431(18):3427-49. Disponible en: https://www.sciencedirect.com/science/article/pii/S0022283619304322 DOI: 10.1016/j.jmb.2019.07.008 PMID 31301408 PMCID PMC6723622 Google Académico Microsoft Académico

Contreras A, Durán AR, Sibrian B, Méndez M V. Resistencia a Fluoroquinolonas en Pseudomonas aeruginosa y Staphylococcus aureus aislados de tejidos blandos en pacientes con Diabetes Mellitus, estado Aragua. Comunidad y Salud [Internet]. 2011;9(2):44-53. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S1690-32932011000200006 SciELO Lilacs Redalyc Google Académico Microsoft Académico

Afriyie DK, Gyansa-Lutterodt M, Amponsah SK, Asare G, Wiredu V, Wormenor E, et al. Susceptibility pattern of uropathogens to ciprofloxacin at the Ghana police hospital. Pan Afr Med J [Internet]. 2015;22:87. Disponible en: https://www.ajol.info/index.php/pamj/article/view/132853 DOI: 10.11604/pamj.2015.22.87.6037 PMID 26848334 PMCID PMC4732620 Google Académico Microsoft Académico

Afriyie DK, Adu LB, Dzradosi M, Amponsah SK, Ohene-Manu P, Manu-Ofei F. Comparative in vitro activity of ciprofloxacin and levofloxacin against isolated uropathogens in Ghana: a pilot study. Pan Afr Med J [Internet]. 2018;30:194. Disponible en: https://www.panafrican-med-journal.com/content/article/30/194/full DOI: 10.11604/pamj.2018.30.194.15457 PMID 30455823 PMCID PMC6235466 Google Académico Microsoft Académico

Yucel N, Citak S, Bayhün S. Antimicrobial Resistance Profile of Staphylococcus aureus Isolated from Clinical Samples and Foods of Animal Origin. Foodborne Pathog Dis [Internet]. 2 de diciembre de 2010;8(3):427-31. Disponible en: https://doi.org/10.1089/fpd.2010.0707 DOI: 10.1089/fpd.2010.0707 PMID 21126193 Google Académico Microsoft Académico

Tiwari HK, Das AK, Sapkota D, Sivrajan K, Pahwa VK. Methicillin resistant Staphylococcus aureus: prevalence and antibiogram in a tertiary care hospital in western Nepal. J Infect Dev Ctries [Internet]. 22 de octubre de 2009;3(09):681-4. Disponible en: https://jidc.org/index.php/journal/article/view/19858569 DOI: 10.3855/jidc.86 PMID 19858569 Google Académico Microsoft Académico

Nesar S, Shoaib MH, Rahim N, Rehman R. Emergence of resistance to fluoroquinolones among Gram positive and Gram negative clinical isolates. Pak J Pharm Sci. octubre de 2012;25(4):877-81. PMID 23010009 Google Académico Microsoft Académico

Mantadakis E, Maraki S, Michailidis L, Gitti Z, Pallikaris IG, Samonis G. Antimicrobial susceptibility of Gram-positive cocci isolated from patients with conjunctivitis and keratitis in Crete, Greece. J Microbiol Immunol Infect [Internet]. 2013;46(1):41-7. Disponible en: https://www.sciencedirect.com/science/article/pii/S1684118211002623 DOI: 10.1016/j.jmii.2011.12.025 PMID 22209987 Google Académico Microsoft Académico

Sohail M, Latif Z. Molecular analysis, biofilm formation, and susceptibility of methicillin-resistant Staphylococcus aureus strains causing community- and health care-associated infections in central venous catheters. Rev Soc Bras Med Trop [Internet]. 2018;51(5):603-9. Disponible en: https://rsbmt.org.br/2018/11/29/molecular-analysis-biofilm-formation-and-susceptibility-of-methicillin-resistant-staphylococcus-aureus-strains-causing-community-and-health-care-associated-infections-in-central-venous-catheters/ DOI: 10.1590/0037-8682-0373-2017 PMID 30304265 SciELO Lilacs Google Académico Microsoft Académico

Hidalgo M, Reyes J, Cárdenas AM, Díaz L, Rincón S, Vanegas N, et al. Perfiles de resistencia a fluoroquinolonas en aislamientos clínicos de cocos Gram positivos provenientes de hospitales colombianos, 1994-2004. Biomedica [Internet]. junio de 2008;28(2):284-94. Disponible en: https://repositorio.unbosque.edu.co/handle/20.500.12495/1557 PMID 18719726 Lilacs Redalyc Google Académico Microsoft Académico

Chang VS, Dhaliwal DK, Raju L, Kowalski RP. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review. Cornea [Internet]. 2015;34(6):698-703. Disponible en: https://journals.lww.com/corneajrnl/Fulltext/2015/06000/Antibiotic_Resistance_in_the_Treatment_of.17.aspx DOI: 10.1097/ICO.0000000000000431 PMID 25811722 PMCID PMC4426026 Google Académico Microsoft Académico

May L, Klein EY, Rothman RE, Laxminarayan R. Trends in Antibiotic Resistance in Coagulase-Negative Staphylococci in the United States, 1999 to 2012. Antimicrob Agents Chemother [Internet]. 1 de marzo de 2014;58(3):1404-1409. Disponible en: http://aac.asm.org/content/58/3/1404.abstract DOI: 10.1128/AAC.01908-13 PMID 24342646 PMCID PMC3957827 Google Académico Microsoft Académico

Bhatt P, Tandel K, Singh A, Mugunthan M, Grover N, Sahni AK. Species distribution and antimicrobial resistance pattern of Coagulase-negative Staphylococci at a tertiary care centre. Med J Armed Forces India [Internet]. 2016;72(1):71-4. Disponible en: https://www.sciencedirect.com/science/article/pii/S0377123714002275 DOI: 10.1016/j.mjafi.2014.12.007 PMID 26900227 PMCID PMC4723702 Google Académico

Sharma V, Jindal N, Devi P. Prevalence of methicillin resistant coagulase negative staphylococci in a tertiary care hospital. Iran J Microbiol [Internet]. 1 de enero de 1970;2(4):185-8. Disponible en: https://ijm.tums.ac.ir/index.php/ijm/article/view/69 PMID 22347570 PMCID: PMC3279789 Google Académico

Nahaei MR, Shahmohammadi MR, Ebrahimi S, Milani M. Detection of Methicillin-Resistant Coagulase-Negative Staphylococci and Surveillance of Antibacterial Resistance in a Multi-Center Study from Iran. Jundishapur J Microbiol [Internet]. 2015;8(8):e19945. Disponible en: https://sites.kowsarpub.com/jjm/articles/56460.html DOI: 10.5812/jjm.19945v2 PMID 26468362 PMCID PMC4600999 Google Académico

McCluskey S, Knapp C. Predicting Antibiotic Resistance, Not Just for Quinolones. Front Microbiol [Internet]. 2011;2:178. Disponible en: https://www.frontiersin.org/article/10.3389/fmicb.2011.00178 DOI: 10.3389/fmicb.2011.00178 PMID 21909335 PMCID: PMC3164100 Google Académico Microsoft Académico

Miller WR, Munita JM, Arias CA. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther [Internet]. 1 de octubre de 2014;12(10):1221-36. Disponible en: https://doi.org/10.1586/14787210.2014.956092 DOI: 10.1586/14787210.2014.956092 PMID 25199988 PMCID PMC4433168 Google Académico Microsoft Académico

Lee G. Ciprofloxacin Resistance in Enterococcus faecalis Strains Isolated From Male Patients With Complicated Urinary Tract Infection. Korean J Urol [Internet]. junio de 2013;54(6):388-93. Disponible en: https://doi.org/10.4111/kju.2013.54.6.388 DOI: 10.4111/kju.2013.54.6.388 PMID 23789048 PMCID PMC3685639 Google Académico Microsoft Académico

Quiñones Pérez D, Marrero D, Falero B, Tamargo I, Llop A, Kobayashi N, et al. Susceptibilidad antimicrobiana y factores de virulencia en especies de Enterococcus causantes de infecciones pediátricas en Cuba. Rev Cubana Med Trop. 2008;60(2):123-9. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0375-07602008000200004&script=sci_arttext&tlng=en SciELO Lilacs Google Académico Microsoft Académico

Urushibara N, Suzaki K, Kawaguchiya M, Aung MS, Shinagawa M, Takahashi S, et al. Contribution of Type II Topoisomerase Mutations to Fluoroquinolone Resistance in Enterococcus faecium from Japanese Clinical Setting. Microb Drug Resist [Internet]. 15 de mayo de 2017;24(1):1-7. Disponible en: https://doi.org/10.1089/mdr.2016.0328 DOI: 10.1089/mdr.2016.0328 PMID 28504916 Google Académico Microsoft Académico

Talaga K, Odrowąż-Konduracka D, Paradowska B, Jagiencarz-Starzec B, Wolak Z, Bulanda M, et al. Typing of Enterococcus spp. strains in 4 hospitals in the Małopolska region in Poland. Adv Clin Exp Med [Internet]. enero de 2018;27(1):111-7. Disponible en: https://www.advances.umed.wroc.pl/en/article/2018/27/1/111/ DOI: 10.17219/acem/68265 PMID 29521051 Google Académico

Adesida SA, Ezenta CC, Adagbada AO, Aladesokan AA, Coker AO. Carriage of multidrug resistant Enterococcus faecium and Enterococcus faecalis among apparently healthy humans. African J Infect Dis. 2017;11(2):83-9. Disponible en: https://www.ajol.info/index.php/ajid/article/view/158491 DOI: 10.21010/ajid.v11i2.11 PMID 28670644 PMCID PMC5476817 Google Académico Microsoft Académico

Haas MK, Dalton K, Knepper BC, Stella SA, Cervantes L, Price CS, et al. Effects of a Syndrome-Specific Antibiotic Stewardship Intervention for Inpatient Community-Acquired Pneumonia. Open Forum Infect Dis [Internet]. 1 de octubre de 2016;3(4):ofw186. Disponible en: https://doi.org/10.1093/ofid/ofw186 DOI: 10.1093/ofid/ofw186 PMID 27747254 PMCID PMC5063573 Google Académico Microsoft Académico

Zhang G, Wang C, Sui Z, Feng J. Insights into the evolutionary trajectories of fluoroquinolone resistance in Streptococcus pneumoniae. J Antimicrob Chemother [Internet]. 1 de septiembre de 2015;70(9):2499-506. Disponible en: https://doi.org/10.1093/jac/dkv134 DOI: 10.1093/jac/dkv134 PMID 26031465 Google Académico Microsoft Académico

Schmitz J, van der Linden M, Al-Lahham A, Levina N, Pletz MW, Imöhl M. Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004–2005 to 2014–2015. Int J Med Microbiol [Internet]. 2017;307(4):216-22. Disponible en: https://www.sciencedirect.com/science/article/pii/S1438422116304271 DOI: 10.1016/j.ijmm.2017.04.003 PMID 28506425 Google Académico Microsoft Académico

Tadesse BT, Ashley EA, Ongarello S, Havumaki J, Wijegoonewardena M, González IJ, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis [Internet]. 2017;17(1):616. Disponible en: https://doi.org/10.1186/s12879-017-2713-1 DOI: 10.1186/s12879-017-2713-1 PMID 28893183 PMCID PMC5594539 Google Académico Microsoft Académico

Patel SN, Melano R, McGeer A, Green K, Low DE. Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada. Ann Clin Microbiol Antimicrob [Internet]. 2010;9(1):3. Disponible en: https://doi.org/10.1186/1476-0711-9-3 DOI: 10.1186/1476-0711-9-3 PMID 20082699 PMCID PMC2823643 Google Académico Microsoft Académico

Tham DWJ, Abubakar U, Tangiisuran B. Prevalence and predictors of antibiotic use among children visiting the Emergency Department in a Tertiary Hospital in Malaysia. Eur J Pediatr [Internet]. 2020;179(5):743-8. Disponible en: https://doi.org/10.1007/s00431-019-03560-z DOI: 10.1007/s00431-019-03560-z PMID 31900590 Google Académico Microsoft Académico

Mamishi S, Moradkhani S, Mahmoudi S, Hosseinpour-Sadeghi R, Pourakbari B. Penicillin-Resistant trend of Streptococcus pneumoniae in Asia: A systematic review. Iran J Microbiol [Internet]. 1 de enero de 1970;6(4):198-210. Disponible en: https://ijm.tums.ac.ir/index.php/ijm/article/view/411 PMID 25802701 PMCID PMC4367934 Google Académico Microsoft Académico

Song J-H, Huh K, Chung DR. Community-Acquired Pneumonia in the Asia-Pacific Region. Semin Respir Crit Care Med. 2016;37(06):839-54. Disponible en: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0036-1592075 DOI: 10.1055/s-0036-1592075 PMID 27960208 PMCID PMC7171710 Google Académico Microsoft Académico

Park M, Kim HS, Kim H-S, Park JY, Song W, Cho HC, et al. Novel Levofloxacin-Resistant Multidrug-Resistant Streptococcus pneumoniae Serotype 11A Isolates, South Korea. Emerg Infect Dis J [Internet]. 2016;22(11):1978. Disponible en: https://wwwnc.cdc.gov/eid/article/22/11/15-1450_article DOI: 10.3201/eid2211.151450 PMID 27767906 PMCID PMC5088008 Google Académico Microsoft Académico

Michel K, Marlise Beatrice BL, Julius Mbekem N, Bienvenue Etogo O. Antibiotics susceptibility pattern of Streptococcus pneumoniae isolated from sputum cultures of human immunodeficiency virus infected patients in Yaounde, Cameroon. Pan Afr Med J [Internet]. 2018;31(16). Disponible en: https://www.panafrican-med-journal.com/content/article/31/16/full DOI: 10.11604/pamj.2018.31.16.11195 PMID 30918544 PMCID PMC6430946 Google Académico Microsoft Académico

Lin J-N, Chang L-L, Lai C-H, Huang Y-H, Chen W-F, Yang C-H, et al. High prevalence of fluoroquinolone-nonsusceptible Streptococcus pyogenes emm12 in Taiwan. Diagn Microbiol Infect Dis [Internet]. 2015;83(2):187-92. Disponible en: https://www.sciencedirect.com/science/article/pii/S0732889315002217 DOI: 10.1016/j.diagmicrobio.2015.06.018 PMID 26234479 Google Académico Microsoft Académico

Shen Y, Cai J, Davies MR, Zhang C, Gao K, Qiao D, et al. Identification and Characterization of Fluoroquinolone Non-susceptible Streptococcus pyogenes Clones Harboring Tetracycline and Macrolide Resistance in Shanghai, China. Front Microbiol [Internet]. 2018;9:542. Disponible en: https://www.frontiersin.org/article/10.3389/fmicb.2018.00542 DOI: 10.3389/fmicb.2018.00542 PMID 29628918 PMCID PMC5876283 Google Académico Microsoft Académico

Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin. J Antimicrob Chemother [Internet]. 1 de mayo de 2009;63(5):886-94. Disponible en: https://doi.org/10.1093/jac/dkp057 DOI: 10.1093/jac/dkp057 PMID 19279051 Google Académico Microsoft Académico

Montes M, Tamayo E, Orden B, Larruskain J, Perez-Trallero E. Prevalence and Clonal Characterization of Streptococcus pyogenes Clinical Isolates with Reduced Fluoroquinolone Susceptibility in Spain. Antimicrob Agents Chemother [Internet]. 1 de enero de 2010;54(1):93-7. Disponible en: http://aac.asm.org/content/54/1/93.abstract DOI: 10.1128/AAC.00780-09 PMID 19805559 PMCID PMC2798512 Google Académico Microsoft Académico

Petrelli D, Di Luca MC, Prenna M, Bernaschi P, Repetto A, Vitali LA. Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy. Eur J Clin Microbiol Infect Dis [Internet]. 2014;33(2):241-4. Disponible en: https://doi.org/10.1007/s10096-013-1950-5 DOI: 10.1007/s10096-013-1950-5 PMID 24002218 Google Académico Microsoft Académico

Pires R, Ardanuy C, Rolo D, Morais A, Brito-Avô A, Gonçalo-Marques J, et al. Emergence of Ciprofloxacin-Nonsusceptible Streptococcus pyogenes Isolates from Healthy Children and Pediatric Patients in Portugal. Antimicrob Agents Chemother [Internet]. 1 de junio de 2010;54(6):2677-80. Disponible en: http://aac.asm.org/content/54/6/2677.abstract DOI: 10.1128/AAC.01536-09 PMID 20350943 PMCID PMC2876401 Google Académico Microsoft Académico

Pinho MD, Melo-Cristino J, Ramirez M. Fluoroquinolone Resistance in Streptococcus dysgalactiae subsp. equisimilis and Evidence for a Shared Global Gene Pool with Streptococcus pyogenes. Antimicrob Agents Chemother [Internet]. 1 de mayo de 2010;54(5):1769-77. Disponible en: http://aac.asm.org/content/54/5/1769.abstract DOI: 10.1128/AAC.01377-09 PMID 20145082 PMCID PMC2863612 Google Académico Microsoft Académico

Van Heirstraeten L, Leten G, Lammens C, Goossens H, Malhotra-Kumar S. Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007–10. J Antimicrob Chemother [Internet]. 1 de noviembre de 2012;67(11):2602-5. Disponible en: https://doi.org/10.1093/jac/dks281 DOI: 10.1093/jac/dks281 PMID 22815354 Google Académico Microsoft Académico

Simoni S, Vincenzi C, Brenciani A, Morroni G, Bagnarelli P, Giovanetti E, et al. Molecular Characterization of Italian Isolates of Fluoroquinolone-Resistant Streptococcus agalactiae and Relationships with Chloramphenicol Resistance. Microb Drug Resist [Internet]. 7 de agosto de 2017;24(3):225-31. Disponible en: https://doi.org/10.1089/mdr.2017.0139 DOI: 10.1089/mdr.2017.0139 PMID 28783417 Google Académico Microsoft Académico

Hays C, Louis M, Plainvert C, Dmytruk N, Touak G, Trieu-Cuot P, et al. Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France. Antimicrob Agents Chemother [Internet]. 1 de diciembre de 2016;60(12):7424-30. Disponible en: http://aac.asm.org/content/60/12/7424.abstract DOI: 10.1128/AAC.01374-16 PMID 27736761 PMCID PMC5119025 Google Académico Microsoft Académico

Piccinelli G, Gargiulo F, Corbellini S, Ravizzola G, Bonfanti C, Caruso A, et al. Emergence of the First Levofloxacin-Resistant Strains of Streptococcus agalactiae Isolated in Italy. Antimicrob Agents Chemother [Internet]. 1 de abril de 2015;59(4):2466-9. Disponible en: http://aac.asm.org/content/59/4/2466.abstract DOI: 10.1128/AAC.05127-14 PMID 25666148 PMCID PMC4356756 Google Académico Microsoft Académico

Ki M, Srinivasan U, Oh KY, Kim MY, Shin J-H, Hong HL, et al. Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea. Eur J Clin Microbiol Infect Dis [Internet]. 2012;31(11):3199-205. Disponible en: https://doi.org/10.1007/s10096-012-1685-8 DOI: 10.1007/s10096-012-1685-8 PMID 22752224 Google Académico Microsoft Académico

Sader HS, Rhomberg PR, Fuhrmeister AS, Mendes RE, Flamm RK, Jones RN. Antimicrobial Resistance Surveillance and New Drug Development. Open Forum Infect Dis [Internet]. 15 de marzo de 2019;6(Suppl 1):S5-13. Disponible en: https://doi.org/10.1093/ofid/ofy345 DOI: 10.1093/ofid/ofy345 PMID 30895210 PMCID PMC6419994 Google Académico Microsoft Académico

Haenni M, Lupo A, Madec J-Y. Antimicrobial Resistance in Streptococcus spp. Microbiol Spectr [Internet]. 2018;6(2). Disponible en: https://www.asmscience.org/content/journal/microbiolspec/10.1128/microbiolspec.ARBA-0008-2017 DOI: 10.1128/microbiolspec.ARBA-0008-2017 PMID 29600772 Google Académico Microsoft Académico

Nakajima T, Nakanishi S, Mason C, Montgomery J, Leggett P, Matsuda M, et al. Population structure and characterization of viridans group streptococci (VGS) isolated from the upper respiratory tract of patients in the community. Ulster Med J [Internet]. septiembre de 2013;82(3):164-8. Disponible en: https://www.ums.ac.uk/082_3.html PMID 24505152 PMCID PMC3913407 Google Académico Microsoft Académico

Munita JM, Arias CA. Mechanisms of Antibiotic Resistance. Microbiol Spectr [Internet]. 2016;4(2). Disponible en: https://www.asmscience.org/content/journal/microbiolspec/10.1128/microbiolspec.VMBF-0016-2015 DOI: 10.1128/microbiolspec.VMBF-0016-2015 PMID 27227291 PMCID PMC4888801 Google Académico

Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ V. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol [Internet]. 2015;13(1):42-51. Disponible en: https://doi.org/10.1038/nrmicro3380 DOI: 10.1038/nrmicro3380 PMID 25435309 Google Académico Microsoft Académico

Pallo-Zimmerman LM, Byron JK, Graves TK. Fluoroquinolones: then and now. Compend Contin Educ Vet. julio de 2010;32(7):E1-9. PMID 20957609 Google Académico Microsoft Académico

Alvarez-Hernandez DA, Garza-Mayen GS, Vazquez-Lopez R. Quinolonas: Perspectivas actuales y mecanismos de resistencia. Rev Chil Infectologiaologia [Internet]. 2015;32(5):499-504. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182015000600002&nrm=iso DOI: 10.4067/S0716-10182015000600002 PMID 26633105 SciELO Lilacs Google Académico

Publicado
2021-05-09
Cómo citar
1.
Castellano-González MJ, Ocando-Chávez JD, Serrano Azuaje AC, Sandoval-Castellano IV. Perfiles de resistencia a fluoroquinolonas en cocos Gram positivos de importancia clínica. Kasmera [Internet]. 9 de mayo de 2021 [citado 18 de octubre de 2021];49(1):e49132301. Disponible en: https://produccioncientificaluz.org/index.php/kasmera/article/view/32301
Sección
Artículos Originales